In the constantly morphing field of protein structure, scientists at The Scripps Research Institute offer yet another surprise: a common "chaperone" protein in cells thought to help other proteins fold has been shown instead to loosen them.
The study was published in the April 3 issue of Nature Structural & Molecular Biology.
The research offers the first structural insights into the shape of a "client" protein in the presence of a helper or "chaperone" protein. Specifically, the study examined the client protein p53 tumor suppressor and its interactions with chaperone heat shock protein 90 (Hsp90).
"It was a real surprise to find that, when bound to Hsp90, p53 is loosened and becomes less ordered, forming a molten globule-like state," said the study's lead investigator, molecular biologist Professor H. Jane Dyson. "This contradicts what everyone thought of as the function of chaperone proteins—to help other proteins fold into a well-defined three-dimensional structure."
The findings add to scientists' new understanding of proteins, now thought not only to constantly change shape to perform different functions, but also to be active when unfolded.
It was once thought that proteins could be active only if they were neatly folded into a compact shape and that this structure defined its function. Then Scripps Research investigators Dyson and Professor Peter Wright, as well as others, discovered that unfolded "disordered" proteins (also known as "intrinsically unstructured proteins") could also be active.
One way these intrinsically disordered proteins act is by folding when they bind to other molecules and performing a function such as potentiating cellular signaling or turning on the transcription of a gene.
The disordered protein might then dissociate from this partner, unfold, and perhaps bind to a different molecule in a new shape. Thus, these proteins can constantly move between unstructured and ordered states, interacting with many different partners as part of the "proteostasis." of the cell.
"We are realizing that proteins are a lot more versatile than we understood in the past," said Dyson.
Breaking New Ground
In the new Nature Structural & Molecular Biology study, the team set out to better understand the structural biology of the Hsp90/p53 complex.
Both Hsp90 and p53 are crucial to cell functioning. About one percent of proteins in a typical cell are Hsp90 chaperone molecules, and they are known to perform a number of functions, including acting as "holding" proteins for hormone receptors. The tumor suppressor p53 is a crucial cell cycle regulator; in fact, most mutations seen in cancers occur in the DNA-binding domain of p53, which is also the site of its interaction with Hsp90.
"A lot of researchers have studied the interactions of Hsp90 and its client proteins," said Dyson. "None of these studies was able to pinpoint either what the client protein looked like in the complex or what part of Hsp90 was contacting the client."
In the new study, the team used protein nuclear magnetic resonance (NMR) spectroscopy; Scripps Research has some of the world's most powerful NMR spectrometers. Still, the research took several years to complete, given the complicated nature of the proteins, their large size, and their weak interactions.
The data ultimately showed Hsp90 acted to loosen up, or unfold, p53.
The authors suggest the interactions of Hsp90 with its client proteins are tuned to tasks as needed within a cell. "Our study demonstrates that the interaction is surprisingly non-specific," said Dyson, "and that rather than making a distinct complex, the Hsp90 causes a change in the overall structure of the client."
Hsp90 could perform other, as-of-yet-unknown functions, she added. "This is just the beginning of understanding how these important, and very common, chaperone proteins are functioning."
The first author of the study was Sung Jean Park of Scripps Research and the Gachon University School of Medicine and Science. In addition to Dyson, other authors of the study are Brendan N. Borin and Maria A. Martinez-Yamout of Scripps Research.
The research was funded by grants from the National Institutes of Health and the Korea Research Foundation.
About The Scripps Research Institute
The Scripps Research Institute is one of the world's largest independent, non-profit biomedical research organizations. Scripps Research is internationally recognized for its discoveries in immunology, molecular and cellular biology, chemistry, neuroscience, and vaccine development, as well as for its insights into autoimmune, cardiovascular, and infectious disease. Headquartered in La Jolla, California, the institute also includes a campus in Jupiter, Florida, where scientists focus on drug discovery and technology development in addition to basic biomedical science. Scripps Research currently employs about 3,000 scientists, staff, postdoctoral fellows, and graduate students on its two campuses. The institute's graduate program, which awards Ph.D. degrees in biology and chemistry, is ranked among the top ten such programs in the nation.
Mika Ono | EurekAlert!
The birth of a new protein
20.10.2017 | University of Arizona
Building New Moss Factories
20.10.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau
University of Maryland researchers contribute to historic detection of gravitational waves and light created by event
On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...
Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.
Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....
Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).
When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...
Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.
How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...
Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.
It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...
17.10.2017 | Event News
10.10.2017 | Event News
10.10.2017 | Event News
20.10.2017 | Information Technology
20.10.2017 | Materials Sciences
20.10.2017 | Interdisciplinary Research